Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2008 by African Malaria Network Trust.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
African Malaria Network Trust
ClinicalTrials.gov Identifier:
NCT00424944
First received: January 19, 2007
Last updated: April 1, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2008
  Estimated Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)